SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech binary events
An SI Board Since March 2003
Posts SubjectMarks Bans
295 36 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
220<Isotechnika> I predict (i) results will be good and (ii) market won'Biomaven-3/17/2006
219Quick google looks promising. Really should have done this a week ago, but beennigel bates-3/17/2006
218I don't follow this one closely but they presented PIII psoriasis data for Qtuck-3/17/2006
217Advisory - Isotechnika to announce clinical data from Phase III psoriasis trial nigel bates-3/17/2006
216I think Jon had the best assessment a few days ago on the Elan board - I don'tom pope-3/6/2006
215It certainly will be if imposes restrictions or delays beyond what it anticipatetom pope-3/6/2006
214Is the Tysabri meeting a binary event?sjemmeri-3/6/2006
213A quick glom at Schwab's site gives Jul 06 volatilities in the 80's.tom pope-11/23/2005
212The market is treating the pexelizumab failure to meet end point as a binary evetom pope-11/23/2005
211Results from the MACE trial for AGIX' AGI-1067 should be out in the first hatuck-11/22/2005
210A longer version: FDA Raises Concerns On Safety of Diabetes Drug By JENNIFER CIan@SI-9/8/2005
209NKTR: FDA Panel votes YES for type I and type II diabetes By Jennifer Corbett Dmarginnayan-9/8/2005
208However the stock is acting nicely. So the ambiguity in the FDA documents seems marginnayan-9/7/2005
207Well, the briefing documents haven't proven binary, we'll see about the tuck-9/7/2005
206Lehman Summary Research Report on NKTR dated Sep 1, 2005: Next Thursday Sept. 8marginnayan-9/6/2005
205The device does seem sub-optimal. One comparison of NKTR might be to AMLN. IRobohogs-9/6/2005
204I think exubera has a very high chance to pass. As far as the stock, one analrkrw-9/5/2005
203Tuck, I've got no real medical/scientific reason to say so, but I could imakeokalani'nui-9/5/2005
202Please see: Message 21674626 DewDewDiligence_on_SI-9/5/2005
201Tuck, PFE seems to have a golden touch with the FDA - a recent example being tIan@SI-9/5/2005
200I think a put bear spread might help in the volatility department (the implied vtuck-9/5/2005
199Be careful - check out the put prices and the vol levels. Stock could drop seveRobohogs-9/5/2005
198Found your reference, finally. finance.messages.yahoo.com I think Pfizer requetuck-9/4/2005
197I clearly remember reading that EMEA was requested to postpone their decision tihmpa-8/15/2005
196What's interesting is that the NDA was filed this May, I believe, and the FDtuck-8/15/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News